Reuters logo
BRIEF-Cymabay Therapeutics names Sujal Shah CEO
October 31, 2017 / 12:45 PM / 19 days ago

BRIEF-Cymabay Therapeutics names Sujal Shah CEO

Oct 31 (Reuters) - Cymabay Therapeutics Inc

* Cymabay announces the appointment of Sujal Shah as president and chief executive officer

* Cymabay Therapeutics Inc says ‍sujal Shah has been serving as interim president and chief executive officer since March 2017​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below